Abstract
Kay Brosien
Chief Operating Officer
Kintiga
Europe wants AI in healthcare but is the regulatory system ready for it?
At x-cardiac, a Charité spin-off building AI-based medical devices for cardiac surgery, we developed one of Europe's first adaptive AI systems: an algorithm that can be fine-tuned on-site in hospitals and is fully certified under the EU Medical Device Regulation.
The process revealed a system with notified bodies paid by the hour, switching costs of €75,000 for a simple certificate transfer, and a framework that is hard to navigate for start-ups.
In his talk, Kay will map out what it takes to bring adaptive AI through the MDR, and what needs to change if Europe is serious about AI in medicine.
Bio
Kay Brosien is Co-Founder and COO of x-cardiac, a digital health spin-off from the German Heart Center of the Charité and Charité – Universitätsmedizin Berlin. With a background in engineering and fluid dynamics, he has spent over eight years building and certifying AI-based medical devices. At x-cardiac, Kay leads the regulatory strategy for one of Europe's first adaptive AI medical devices, a prognostic algorithm certified under the MDR (class IIa) that can be fine-tuned on-site in hospitals. He is a member of a policy advisory committee for the German Federal Ministry of Research, Technology, and Space.
Join us
Everyone is welcome, space is limited. Registration via Luma is required. Subscribe to our newsletter for priority invitations to upcoming events.
18:30 Doors open
19:00 Talk starts
19:45 Drinks and networking